From Bond-Building Pioneer to Henkel’s Prestige Anchor
Olaplex’s rise from salon secret to global phenomenon explains why it sits at the centre of Henkel’s latest push in premium hair care. Created by Dean and Darcy Christal with chemists Craig Hawker and Eric Pressly, Olaplex introduced a patented bond-building molecule that transformed how professionals approached bleaching and chemical services. The brand’s early salon-only strategy built credibility, while its at-home No.3 Hair Perfector and subsequent launch into Sephora turned it into a consumer sensation. Strong revenue growth and a public listing drew private equity and strategic suitors. Henkel’s decision to acquire Olaplex in a US$1.4bn (approx. RM6.4bn) deal signals a deliberate move into prestige treatment-led hair care. In the context of wider hair care industry consolidation, this Olaplex Henkel buyout gives the German group a science-led flagship that appeals to both professional stylists and ingredient-savvy consumers.
Balancing Prestige and Mass: The Not Your Mother’s Play
Henkel’s acquisition of Not Your Mother’s shows that its hair strategy is not limited to the high end. While Olaplex strengthens its presence in premium, treatment-driven hair care, Not Your Mother’s brings scale in trend-focused, mass-market styling and care. Together, these Henkel hair care acquisitions reshape the company’s portfolio to span both professional and consumer channels, as well as prestige and value segments. The deals are not without short-term cost: Henkel’s group sales in the first quarter fell 5.5%, with recent M&A activity, including Olaplex and Not Your Mother’s, reducing reported sales by 2.1% even as they contributed more than €1.6bn in additional income. Yet organically, Consumer Brands still grew, underscoring how the company is willing to accept near-term accounting drag to build long-term competitive scale in hair care.
Hair Care Shines Amid a Mixed Quarter
Henkel’s latest results highlight why hair care sits at the centre of its growth agenda. Overall Consumer Brands sales declined in reported terms, reflecting foreign exchange headwinds and portfolio changes. However, organically, the division increased sales by 1.8%, with the hair business delivering very strong 5.1% organic growth. Hair colorants provided the strongest contribution, while both consumer and professional hair segments posted gains. This resilience contrasts with flatter performance in Laundry & Home Care, where only modest growth in categories like hand dishwashing offset weaker fabric cleaning. Regionally, performance was uneven, but North America and high-growth regions helped support momentum. The numbers suggest Henkel is doubling down where it sees structural upside: hair care, supported by brand acquisitions and a more premium mix. In a consolidating market, this focus positions Henkel to challenge incumbents across salon, retail, and e-commerce channels.
Betting on Biotech: Henkel Ventures Backs Ruka
Henkel is not relying solely on buying established brands; it is also planting flags in emerging biotech hair innovation. Henkel Ventures co-led a US$4.5m (approx. RM20.6m) funding round for Ruka, a materials-focused beauty start-up working at the intersection of textured hair and advanced fiber science. Ruka’s portfolio spans extensions, wigs, styling products, and tools, but investor attention centres on Synths², a lab-grown collagen-based hair fibre. Unlike conventional synthetic extensions that depend on plastic polymers, or human hair with opaque supply chains, Synths² is designed to be biodegradable, hypoallergenic, and specifically tuned to mimic curls, coils, and kinks. The investment will support scaling production, expanding retail reach, and backing Ruka’s entry into the US market. For Henkel, the deal offers early access to lab-grown hair extensions technology and signals strategic interest in cleaner, more traceable alternatives within the extensions category.
A Dual-Track Path to Hair Care Leadership
Taken together, Henkel’s recent moves point to a dual-track strategy to reshape its role in global hair care. On one side, the company is driving hair care industry consolidation through major acquisitions such as Olaplex and Not Your Mother’s, widening its coverage from prestige treatment systems to mass-market styling. On the other, Henkel Ventures is seeding the future with investments in biotech hair innovation, exemplified by its backing of Ruka’s lab-grown hair extensions platform Synths². This combination positions Henkel across the value chain: established brands deliver scale and immediate earnings power, while early-stage technologies provide optionality in new, sustainability-focused categories. As consumer expectations around efficacy, ethics, and environmental impact rise, Henkel’s blend of M&A and venture activity could give it a structural advantage in the next generation of hair care, from salon chairs to braided styles built on lab-grown fibres.